Disopyramide Phosphate Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Disopyramide Phosphate Capsule, Extended Release (capsule, extended release) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Aug 24, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0025-2742-31
Dosage Form
Capsule, Extended Release
Presentation
Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)
Initial Posting
Aug 24, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.